[1]冯莉 林万鹏 郑丽婷 游紫阳 杨骄霞.经皮冠状动脉介入治疗后早期胸痛相关因素研究现状[J].心血管病学进展,2022,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.010]
 FENG Li,LIN Wanpeng,ZHENG Liting,et al.Research Status of Related Factors of Early Chest Pain After?ercutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.010]
点击复制

经皮冠状动脉介入治疗后早期胸痛相关因素研究现状()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年11期
页码:
1007
栏目:
综述
出版日期:
2022-11-25

文章信息/Info

Title:
Research Status of Related Factors of Early Chest Pain After?ercutaneous Coronary Intervention
作者:
冯莉 林万鹏1 郑丽婷1 游紫阳1 杨骄霞
(1.牡丹江医学院,黑龙江 牡丹江 157011;2.牡丹江医学院附属红旗医院心血管内科,黑龙江 牡丹江 157011)
Author(s):
FENG Li1 LIN Wanpeng1 ZHENG Liting1YOU Ziyang1 YANG Jiaoxia2?/html>
(1.Mudanjiang Medical University,Mudanjiang 157011,Heilongjiang,China; 2.Department of Cardiology,Hongqi Hospital Affiliated to Mudanjiang Medical University,Mudanjiang 157011,Heilongjiang,China)
关键词:
经皮冠状动脉介入治疗胸痛冠心病
Keywords:
Percutaneous coronary interventionChest pain Coronary heart disease
DOI:
10.16806/j.cnki.issn.1004-3934.2022.11.010
摘要:
经皮冠状动脉介入治疗(PCI)是冠心病治疗的重要手段之一,能减轻或消除冠状动脉狭窄或闭塞,恢复心肌的充足血液供应,缓解临床症状。PCI成功后早期胸痛(即术后48 h内出现的胸痛)是一种常见的临床症状,约占全部患者的1/3。然而成功PCI后早期持续性胸痛的病理生理具有异质性,观察胸痛的特点并能正确地判断出疼痛形成的原因,选取合适的治疗方案对挽救患者生命具有重要意义。现将PCI后早期持续性胸痛因素分为缺血性胸痛和非缺血性胸痛,缺血性胸痛可引起患者突然严重的心律失常、休克以及原因不明的严重心力衰竭,必须及时、准确地治疗与处理。非缺血性胸痛虽然不会引起严重的心血管并发症,但可使患者生活质量下降。现旨在分析PCI后早期胸痛持续存在的相关原因,综合其最新研究进展对PCI后早期胸痛相关因素进行论述。
Abstract:
Percutaneous coronary intervention(PCI) is one of the important methods for the treatment of coronary heart disease,which can alleviate or eliminate coronary artery stenosis or occlusion,restore sufficient blood supply to myocardium,and relieve clinical symptoms.?Early chest pain after successful PCI (chest pain within 48 hours after operation) is a common clinical symptom,accounting for about 1 /3 of all patients. However,the pathophysiology of early persistent chest pain after successful PCI is heterogeneous. It is important to observe the characteristics of chest pain and correctly judge the cause of pain formation,and select appropriate treatment plan to save the patient ’s life.Now,the factors of early persistent chest pain after PCI are divided into ischemic chest pain and non-ischemic chest pain. Ischemic chest pain can cause sudden severe arrhythmia,shock and severe heart failure of unknown cause,which must be treated and treated timely and accurately. Although non-ischemic chest pain does not cause serious cardiovascular complications,it can reduce the quality of life of patients. The purpose of this article is to analyze the related causes of early chest pain after PCI,and discuss the related factors of early chest pain after PCI based on the latest research progress

参考文献/References:

[1] Rozenbaum Z,Weisz G. What we know and what we think we know:perception of chest pain early after percutaneous coronary interventions[J].?Cardiovasc Revasc Med,2020,21(12):1523-1524.

[2] Taha Y,Bhatt DL,Mukherjee D,et al. Early post-percutaneous coronary i ntervention chest pain:a nationwide survey on interventional cardiologists’ perspective[J]. Cardiovasc Revasc Med,2020,21(12):1517-1522.

[3] Schüepp M,Ullmer E,Weinbacher M,et al. Chest pain early after percutaneous coronary intervention:incidence and relation to ECG changes,cardiac enzymes and follow-up events[J].J Invasive Cardiol,2001,13(3):211-216.

[4]Ullrich H,Münzel T,Gori T. Coronary stent thrombosis—Predictors and prevention[J].Dtsch Arztebl Int,2020,117(18):320-326.

[5] 朱永翔,蔡金赞,朱灏,等.生物可吸收支架术后早期支架内血栓形成的可能因素及处理[J].中国循环杂志,2018,33(3):296-298.

[6]Brancati MF,Burzotta F,Trani C,et al. Coronary stents and vascular response to implantation:literature review [J]. Pragmat Obs Res,2017,8:137-148.

[7]Wang YP,Ding L,Zhang RT,et al. Analysis of risk factors for early stent thrombosis in the Chinese population:a multicenter restrospective study [J]. World J Emerg Med,2021,12(3):192-197.

[8]Iakovou I,Schmidt T,Bonizzoni E,et al. Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents[J]. JAMA ,2005,293(17):2126-2130.

[9]Nakano M,Yahagi K,Otsuka F,et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome:an ex vivo human autopsy study[J].?J Am Coll Cardiol,2014,63(23):2510-2520.

[10] 李晓冉,赵笑男,王剑飞,等.PCI后胸痛的识别与处理[J]. 中国循证心血管医学杂志,2020,12(6):765-768.

[11]Gaba P,Gersh BJ,Ali ZA,et al. Complete versus incomplete coronary revascularization:definitions,assessment and outcomes[J]. Nat Rev Cardiol,2021,18(3):155-168.

[12] Park JJ,Chun EJ,Cho YS,et al. Potential predictors of side-branch occlusion in bifurcation lesions after percutaneous coronary intervention:a coronary CT angiography study[J].?Radiology,2014,271(3):711-720.

[13] 陈延强.冠心病分叉病变介入治疗中边支闭塞的处理策略[J].心血管外科杂志(电子版),2020,9(1):16-17.

[14] Konijnenberg LSF,Damman P,Duncker DJ,et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction [J].Cardiovasc Res,2020,116(4):787-805.

[15]Chalikias G,Tziakas D. Slow coronary flow:pathophysiology,clinical implications,and therapeutic management[J].Angiology,2021,72(9):808-818.

[16] Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction [J]. Eur Heart J,2016,37(13):1024-1033.

[17] Benamer H,Saighi Bouaouina M,Masri A,et al. Vasospastic angina: an under-diagnosed pathology[J].?Ann Cardiol Angeiol(Paris),2019,68(5):341-346.

[18] Benamer H,Millien V. Coronary spasm a diagnostic and therapeutic challenge[J]. Presse Med,2018,47(9):798-803.

[19]丁娣,王齐兵. 冠脉痉挛及其诊治的研究进展[J].上海医药,2021,42(13):39-42.

[20]Meng LP,Wang P,Peng F. Acute coronary artery stent thrombosis caused by a spasm:a case report [J].World J Clin Cases,2022,10(9):2923-2930.

[21]Yasue H,Mizuno Y,Harada E. Coronary artery spasm—Clinical features,pathogenesis and treatment[J].Proc Jpn Acad Ser B Phys Biol Sci,2019,95(2):53-66.

[22] Jewulski J,Khanal S,Dahal K. Coronary vasospasm:a narrative review [J].World J Cardiol,2021,13(9):456-463.

[23]Mangiacapra F,del Buono MG,Abbate A,et al. Role of endothelial dysfunction in determining angina after percutaneous coronary intervention:learning from pathophysiology to optimize treatment[J]. Prog Cardiovasc Dis,2020,63(3):233-242.

[24]聂祥,樊佳慧,陈琛,等. 冠状动脉微血管功能障碍与心脏病[J]. 中国科学:生命科学,2022,52(5):748-759.

[25]Taqueti VR,di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeuticoptions:JACC state-of-the-art review[J].J Am Coll Cardiol,2018,72(21):2625-2641.

[26]Piper HM,García-Dorado D,Ovize M. A fresh look at reperfusion injury[J].Cardiovasc Res,1998,38(2):291-300.

[27]Eltzschig HK,Eckle T. Ischemia and reperfusion—From mechanism to translation[J].Nat Med,2011,17(11):1391-1401.

[28]Fr?hlich GM,Meier P,White SK,et al. Myocardial reperfusion injury:looking beyond primary PCI[J].Eur Heart J,2013,34(23):1714-1722.

[29] Li G,Tian Y,Zhang Q,et al. The predictive effect of negative psychological emotions of anxiety and depression on the poor prognosis of CHD patients with stent implantation and the improvement of clinical intervention measures[J].Comput Math Methods Med,2022,2022:2534277.

[30]晁田田,张大武,王承龙.冠心病合并广泛性焦虑障碍的病理生理学机制研究进展[J].中西医结合心脑血管病杂志,2020,18(18):2998-3002.

[31] Zhou M,Yu Y,Luo X,et al. Myocardial ischemia-reperfusion injury:therapeutics from a mitochondria-centric perspective[J].?Cardiology,2021,146(6):781-792.

[32] Ma Z,Ning B,Wu D,et al. Correlation between culprit vessel/tirofiban and reperfusion bradyarrhythmia in patients with ST-segment elevation myocardial infarction after emergency PCI[J].Eur Rev Med Pharmacol Sci,2021,25(16):5137-5144.

[33] Kalarus Z,Svendsen JH,Capodanno D,et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization:an European Heart Rhythm Association(EHRA) consensus document,endorsed by the European Association of Percutaneous Cardiovascular Interventions(EAPCI),and European Acute Cardiovascular Care Association(ACCA) [J].Europace,2019,21(10):1603-1604.

[34] Kini AS,Lee P,Mitre CA,et al. Postprocedure chest pain after coronary stenting:implications on clinical restenosis[J].J Am Coll Cardiol,2003,41(1):33-38.

[35] Chang CC,Chen YC,Ong ET,et al. Chest pain after percutaneous coronary intervention in patients with stable angina[J]. Clin Interv Aging,2016,11:1123-1128.

[36]陈剑荣. 心源性与非心源性急性胸痛的临床特征比较[J]. 临床合理用药杂志,2020,13(25):145-146.

[37]刘新光,迟雁. 非心源性胸痛[J]. 中国实用内科杂志,2007,27(8):571-573.

相似文献/References:

[1]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
 HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(11):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[2]贺彩红 荣晶晶 潘宏伟.定量血流分数在急性心肌梗死中的应用进展[J].心血管病学进展,2021,(4):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
 HE Caihong,RONG Jingjing,PAN Hongwei.Progress in the Application of Quantitative Flow Ratio in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(11):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
[3]王继航 田进文 王建 郭毅 周星儿 付振虹 沈明志 刘亮.基于人工智能可穿戴设备及物联网的胸痛区域平台研究进展[J].心血管病学进展,2021,(6):492.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.004]
 WANG JihangTIAN JinwenWANG JianGUO YiZHOU XingerGUO utingFU ZhenhongSHEN MingzhiLIU Liang.Chest Pain Area Platform based on Artificial Intelligence Wearable Devices and Internet of Things[J].Advances in Cardiovascular Diseases,2021,(11):492.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.004]
[4]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
 CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(11):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[5]梁晨笛 秦纲.经皮冠状动脉介入诊疗中穿刺路径研究进展[J].心血管病学进展,2022,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 LIANG Chendi,QIN Gang.Puncture Routes in Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(11):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[6]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
 MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(11):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[7]张爽 吴娜琼.腔内影像学在冠状动脉支架内再狭窄诊治应用中的研究进展[J].心血管病学进展,2022,(5):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
 ZHANG Shuang,WU Na qiong.Application of Intravascular Imaging in Diagnosis and Treatment of Coronary In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(11):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
[8]管翔 王宇 张成糕 周健 张艺 李庆国.经皮心室辅助装置在复杂高危冠状动脉介入治疗中的应用进展[J].心血管病学进展,2022,(5):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
 GUAN Xiang,WANG Yu,ZHANG Chenggao,et al.Application Progress of Percutaneous Ventricular Assist Device in Complex High-Risk Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(11):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
[9]刘文 魏芳晶.药物涂层球囊在真性分叉病变中的研究进展[J].心血管病学进展,2022,(6):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
 LIU WenWEI Fangjing.Study of Drug-Coated?Balloon in?rue Coronary Bifurcation Lesions[J].Advances in Cardiovascular Diseases,2022,(11):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
[10]宋艳华 来春林 杨五小.急性 ST段抬高型心肌梗死患者微血管功能障碍的研究进展[J].心血管病学进展,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
 SONG Yanhua,LAI Chunlin,YANG Wuxiao.Microvascular Dysfunction in Patients with Acute ST-Segment?levation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(11):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]

更新日期/Last Update: 2023-01-31